Infimer Ltd (INFR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Infimer Ltd (INFR) has a cash flow conversion efficiency ratio of -0.364x as of June 2019. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-2.23 Million ≈ $-5.98K USD) by net assets (ILA6.13 Million ≈ $16.43K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Infimer Ltd - Cash Flow Conversion Efficiency Trend (2005–2018)
This chart illustrates how Infimer Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Infimer Ltd (INFR) financial obligations for a breakdown of total debt and financial obligations.
Infimer Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Infimer Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Stenocare AS
CO:STENO
|
-0.319x |
|
Genuit Group plc
LSE:GEN
|
0.035x |
|
Agroz Inc. Ordinary Shares
NASDAQ:AGRZ
|
N/A |
|
Ssif Broker Cl
RO:BRK
|
2.864x |
|
Fatfish Group Ltd
AU:FFG
|
0.106x |
|
Imperial Pacific Ltd
AU:IPC
|
0.024x |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
-0.385x |
|
Mountain Province Diamonds Inc
TO:MPVD
|
0.020x |
Annual Cash Flow Conversion Efficiency for Infimer Ltd (2005–2018)
The table below shows the annual cash flow conversion efficiency of Infimer Ltd from 2005 to 2018. For the full company profile with market capitalisation and key ratios, see INFR market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2018-12-31 | ILA8.70 Million ≈ $23.33K |
ILA-7.89 Million ≈ $-21.16K |
-0.907x | +54.04% |
| 2017-12-31 | ILA2.51 Million ≈ $6.73K |
ILA-4.96 Million ≈ $-13.29K |
-1.973x | -90.74% |
| 2016-12-31 | ILA6.14 Million ≈ $16.46K |
ILA-6.35 Million ≈ $-17.02K |
-1.034x | -0.08% |
| 2015-12-31 | ILA4.23 Million ≈ $11.35K |
ILA-4.37 Million ≈ $-11.73K |
-1.034x | -681.02% |
| 2014-12-31 | ILA7.47 Million ≈ $20.02K |
ILA-988.00K ≈ $-2.65K |
-0.132x | -356.52% |
| 2013-12-31 | ILA8.04 Million ≈ $21.55K |
ILA-233.00K ≈ $-624.66 |
-0.029x | +90.51% |
| 2012-12-31 | ILA12.04 Million ≈ $32.29K |
ILA-3.68 Million ≈ $-9.86K |
-0.305x | +62.50% |
| 2011-12-31 | ILA3.29 Million ≈ $8.83K |
ILA-2.68 Million ≈ $-7.19K |
-0.814x | -449.31% |
| 2010-12-31 | ILA5.31 Million ≈ $14.24K |
ILA1.24 Million ≈ $3.32K |
0.233x | +17.15% |
| 2009-12-31 | ILA11.44 Million ≈ $30.66K |
ILA2.28 Million ≈ $6.10K |
0.199x | +100.56% |
| 2005-12-31 | ILA-227.00K ≈ $-608.58 |
ILA8.01 Million ≈ $21.47K |
-35.278x | -- |
About Infimer Ltd
Infimer Ltd develops technology and production processes for converting municipal solid waste. The company produces Infimer, a thermoplastic composite material that serves as an alternative to the raw materials used by the plastics industry, and minimizes cost of household landfilling and the carbon footprints. Its Infimer range of thermoplastic composite materials are used for the production of … Read more